Advertisement
Advertisement
AXSM
Axsome Therapeutics, Inc
220.75
USDSponsored
+9.63
+4.56%
Sep 11, 15:59 UTC -4
Closed
After-Market
220.50
-0.25
-0.11%
Axsome Therapeutics, Inc Financial Snapshot
| Market Cap | 11.55B |
| Beta | 0.71 |
| Earnings Per Share (EPS) | -3.75 |
| Price-to-Book (P/B) Ratio | 130.11 |
| Operating Margin | -25.64% |
| Total Debt/Equity (D/E) | 236.47% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -265.55% |
| Current Ratio | 1.43% |
| Free Cash Flow | -54.22M |
